Lynx Investment Advisory’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-261
Closed -$86.1K 785
2024
Q2
$86.1K Buy
+261
New +$86.1K 0.06% 191